Ethical issues with newborn screening in the genomics era

Annual Review of Genomics and Human Genetics

Volumn 13, Issue , 2012, Pages 381-393

  Tarini, Beth A ^a   Goldenberg, Aaron J ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ethics; newborn screening policy; whole genome sequencing

Indexed keywords

BLOOD SPOT STORAGE; BLOOD STORAGE; CLINICAL ASSESSMENT; COMMUNITY CARE; EDUCATION; FALSE POSITIVE RESULT; FOLLOW UP; GENE SEQUENCE; GENOMICS; HETEROZYGOTE; HUMAN; MEDICAL ETHICS; NEWBORN SCREENING; PARENTAL SCHOOLING; REVIEW;

DRIED BLOOD SPOT TESTING; GENETIC COUNSELING; GENETIC TESTING; GENOMICS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH POLICY; HUMANS; INFANT, NEWBORN; MANDATORY TESTING; NEONATAL SCREENING; STATE GOVERNMENT; UNITED STATES;

EID: 84872446157     PISSN: 15278204     EISSN: 1545293X     Source Type: Book Series    
DOI: 10.1146/annurev-genom-090711-163741     Document Type: Review

References (70)

1. Alexander D, van Dyck PC. 2006. A vision of the future of newborn screening. Pediatrics 117:S350-54 (Pubitemid 46071323)
2. Am. Acad. Pediatr. Newborn Screen. Task Force. 2000. Newborn screening: a blueprint for the future executive summary: Newborn Screening Task Force report. Pediatrics 106:389-427
3. Am. Coll. Med. Genet. 2005. Newborn screening: toward a uniform screening panel and system. Rep., Am. Coll. Med. Genet., Rockville, MD
4. Am. Coll. Obstet. Gynecol.Comm. Genet. 2011.Committee opinion no. 481: newborn screening. Obstet. Gynecol. 117:762-65
5. Bearder et al. v. State of Minnesota. 2010. Minn. Court of Appeals A10-101 (Aug. 24)
6. Beleno v. Texas Department of State Health Services. 2009. US Dist. Court West. Dist. Tex. 5SA-09-CA-0188-FB (Mar. 3)
7. Benson JM, Therrell BL Jr. 2010. History and current status of newborn screening for hemoglobinopathies. Semin. Perinatol. 34:134-44
8. Borowitz D, Parad RB, Sharp JK, Sabadosa KA, Robinson KA, et al. 2009. Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. J. Pediatr. 155:S106-16
9. Botkin JR, Clayton EW, Fost NC, Burke W, Murray TH, et al. 2006. Newborn screening technology: proceed with caution. Pediatrics 117:1793-99 (Pubitemid 46071411)
10. Clayton EW. 2005. Talking with parents before newborn screening. J. Pediatr. 147:S26-29 (Pubitemid 41400255)
11. Cookson R, McCabe C, Tsuchiya A. 2008. Public healthcare resource allocation and the Rule of Rescue. J. Med. Ethics 34:540-44
12. Davis TC, Humiston SG, Arnold CL, Bocchini JA Jr, Bass PF III, et al. 2006. Recommendations for effective newborn screening communication: results of focus groups with parents, providers, and experts. Pediatrics 117:S326-40 (Pubitemid 46071321)
13. Diem K. 2004. Newborn screening-should it be part of prenatal care? Am. J. Obstet. Gynecol. 190:874 (Pubitemid 38561498)
14. Farrell MH, Certain L, Farrell P. 2001. Genetic counseling and risk communication services of newborn screening programs. Arch. Pediatr. Adolesc. Med. 155:120-26 (Pubitemid 32128379)
15. Farrell MH, Deuster L, Donovan J, Christopher S. 2008. Pediatric residents' use of jargon during counseling about newborn genetic screening results. Pediatrics 122:243-49
16. Farrell MH, La Pean A, Ladouceur L. 2005. Content of communication by pediatric residents after newborn genetic screening. Pediatrics 116:1492-98 (Pubitemid 46061100)
17. Farrell MH, Speiser J, Deuster L, Christopher S. 2012. Child health providers' precautionary discussion of emotions during communication about results of newborn genetic screening. Arch. Pediatr. Adolesc. Med. 166:62-67
18. Faulkner LA, Feuchtbaum LB, Graham S, Bolstad JP, Cunningham GC. 2006. The newborn screening educational gap: what prenatal care providers do compared with what is expected. Am. J. Obstet. Gynecol. 194:131-37 (Pubitemid 43017787)
19. Feuchtbaum L, Cunninghamn G, Sciortino S. 2007. Questioning the need for informed consent: a case study of California's experience with a pilot newborn screening project. J. Empir. Res. Hum. Res. Ethics 2:3-14
20. Feuchtbaum L, Faulkner L, Verghese S. 2006. Tandem mass spectrometry program implementation challenges for state newborn screening programs: national survey of barriers and issues. Pediatrics 117:S253-60 (Pubitemid 46071312)
21. Fyro K, Bodegard G. 1987. Four-year follow-up of psychological reactions to false positive screening tests for congenital hypothyroidism. Acta Paediatr. Scand. 76:107-14 (Pubitemid 17020972)
22. Goldenberg AJ, Sharp RR. 2011. The ethical hazards and programmatic challenges of genomic newborn screening. JAMA 307:461-62
23. Gostin L. 2000. Public Health Law: Power, Duty, Restraint. Berkeley: Univ. Calif. Press
24. Gurian EA, Kinnamon DD, Henry JJ, Waisbren SE. 2006. Expanded newborn screening for biochemical disorders: the effect of a false-positive result. Pediatrics 117:1915-21 (Pubitemid 46071234)
25. Guthrie R. 1963. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32:318-43
26. Hasegawa LE, Fergus KA, Ojeda N, Au SM. 2011. Parental attitudes toward ethical and social issues surrounding the expansion of newborn screening using new technologies. Public Health Genomics 14:298-306
27. Hoff T, Ayoob M, Therrell BL. 2007. Long-term follow-up data collection and use in state newborn screening programs. Arch. Pediatr. Adolesc. Med. 161:994-1000 (Pubitemid 47529417)
28. Holtzman NA, Watson MS, eds. 1998. Promoting Safe and Effective Genetic Testing in the United States: Final Report of the Task Force on Genetic Testing. Baltimore: Johns Hopkins Univ. Press
29. Johnson K, Lloyd-Puryear MA, Mann MY, Ramos LR, Therrell BL. 2006. Financing state newborn screening programs: sources and uses of funds. Pediatrics 117:S270-79 (Pubitemid 46071314)
30. Kai J, Ulph F, Cullinan T, Qureshi N. 2009.Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice. Health Technol. Assess. 13:1-82
31. Kemper AR, Fant KE, Clark SJ. 2005. Informing parents about newborn screening. Public Health Nurs. 22:332-38 (Pubitemid 41261313)
32. Kemper AR, UrenRL, MoseleyKL, Clark SJ. 2006. Primary care physicians' attitudes regarding follow-up care for children with positive newborn screening results. Pediatrics 118:1836-41 (Pubitemid 46393663)
33. Kim S, Lloyd-Puryear MA, Tonniges TF. 2003. Examination of the communication practices between state newborn screening programs and the medical home. Pediatrics 111:E120-26
34. Kohane IS, Masys DR, Altman RB. 2006. The incidentalome: a threat to genomic medicine. JAMA 296:212-15 (Pubitemid 44050375)
35. Kraszewski J, Burke T, Rosenbaum S. 2006. Legal issues in newborn screening: implications for public health practice and policy. Public Health Rep. 121:92-94 (Pubitemid 43200192)
36. Kwon JM, Steiner RD. 2011. "I'm fine; I'm just waiting for my disease": the new and growing class of presymptomatic patients. Neurology 77:522-23
37. Lang CW, Stark AP, Acharya K, Ross LF. 2009. Maternal knowledge and attitudes about newborn screening for sickle cell disease and cystic fibrosis. Am. J. Med. Genet. A 149A:2424-29
38. Lanie AD, Jayaratne TE, Sheldon JP, Kardia SL, Anderson ES, et al. 2004. Exploring the public understanding of basic genetic concepts. J. Genet. Couns. 13:305-20 (Pubitemid 38998455)
39. La Pean A, Farrell MH. 2005. Initially misleading communication of carrier results after newborn genetic screening. Pediatrics 116:1499-505 (Pubitemid 46056500)
40. Lenke RR, Levy HL. 1980. Maternal phenylketonuria and hyperphenylalaninemia-an international survey of the outcome of untreated and treated pregnancies. N. Engl. J. Med. 303:1202-8 (Pubitemid 11207585)
41. Lipstein EA, Perrin JM, Waisbren SE, Prosser LA. 2009. Impact of false-positive newborn metabolic screening results on early health care utilization. Genet. Med. 11:716-21
42. Lynch E, Dezen T, Dewey LA. 2010. National standard for newborn screening is announced. March of Dimes, May 21. http://www.marchofdimes.Com/aboutus/ 49267-65861.asp
43. Mandl KD, Feit S, Larson C, Kohane IS. 2002. Newborn screening program practices in the United States: notification, research, and consent. Pediatrics 109:269-73 (Pubitemid 34126868)
44. McKie J, Richardson J. 2003. The rule of rescue. Soc. Sci. Med. 56:2407-19 (Pubitemid 36555359)
45. Moyer VA, Calonge N, Teutsch SM, Botkin JR. 2008. Expanding newborn screening: process, policy, and priorities. Hastings Cent. Rep. 38:32-39
46. Natl. Newborn Screen. Genet. Res. Cent. 2010. National newborn screening status report [2010]. Rep., Natl. Newborn Screen. Genet. Res. Cent., Austin, TX
47. Natl. Newborn Screen. Genet. Res. Cent. 2011. National newborn screening status report [2011]. Rep., Natl. Newborn Screen. Genet. Res. Cent., Austin, TX
48. Neb. Rev. Stat. § 71-519-71-524
49. Newborn Screening Saves Lives Act of 2007. Pub. L. No. 110-204, 122 Stat. 705
50. ParadRB, ComeauAM. 2005. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm. J. Pediatr. 147:S78-82 (Pubitemid 41400264)
51. Patient Protection and Affordable Care Act of 2010. Pub. L. No. 111-148, 124 Stat. 119
52. Paul DB. 1998. The History of Newborn Phenylketonuria Screening in the US. Baltimore: Johns Hopkins Univ. Press
53. Paul DB. 2008. Patient advocacy in newborn screening: continuities and discontinuities. Am. J. Med. Genet. C 148C:8-14 (Pubitemid 351294847)
54. Perrin JM. 2009. Krabbe disease. Presented at Meet. Secret. Advis.Comm. Heritable Disord. Newborns Child., 19th, Bethesda, MD, Sept. 24-25
55. Perrin JM, Knapp AA, Browning MF, Comeau AM, Green NS, et al. 2010. An evidence development process for newborn screening. Genet. Med. 12:131-34
56. Pres. Counc. Bioeth. 2008. The Changing Moral Focus of Newborn Screening: An Ethical Analysis by the President's Council on Bioethics. Washington, DC: Pres. Counc. Bioeth.
57. Ross LF. 2010. Mandatory versus voluntary consent for newborn screening? Kennedy Inst. Ethics J. 20:299-328
58. Rothenberg MB, Sills EM. 1968. Iatrogenesis: the PKU anxiety syndrome. J. Am. Acad. Child Psychiatry 7:689-92
59. Rutkow IM, Lipton JM. 1974. Some negative aspects of state health departments' policies related to screening for sickle cell anemia. Am. J. Public Health 64:217-21
60. Stadler SC, Polanetz R, Maier EM, Heidenreich SC, Niederer B, et al. 2006. Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: population heterogeneity of MCCA and MCCB mutations and impact on risk assessment. Hum. Mutat. 27:748-59 (Pubitemid 44205068)
61. Stoddard JJ, Farrell PM. 1997. State-to-state variations in newborn screening policies. Arch. Pediatr. Adolesc. Med. 151:561-64 (Pubitemid 27262278)
62. Tarini BA. 2007. The current revolution in newborn screening: new technology, old controversies. Arch. Pediatr. Adolesc. Med. 161:1-6
63. Tarini BA. 2011. Storage and use of residual newborn screening blood spots: a public policy emergency. Genet. Med. 13:619-20
64. Tarini BA, Christakis DA, Welch HG. 2006. State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results. Pediatrics 118:448-56 (Pubitemid 46085397)
65. Tarini BA, Clark SJ, Pilli S, Dombkowski KJ, Korzeniewski SJ, et al. 2011. False-positive newborn screening result and future health care use in a state Medicaid cohort. Pediatrics 128:715-22
66. Therrell BL, Johnson A, Williams D. 2006. Status of newborn screening programs in the United States. Pediatrics 117:S212-52 (Pubitemid 46071311)
67. van Maldegem BT, Duran M, Wanders RJ, Niezen-Koning KE, Hogeveen M, et al. 2006. Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency. JAMA 296:943-52 (Pubitemid 44285371)
68. Waisbren SE, Albers S, Amato S, Ampola M, Brewster TG, et al. 2003. Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress. JAMA 290:2564-72 (Pubitemid 37443286)
69. Waisbren SE, HanleyW, Levy HL, Shifrin H, Allred E, et al. 2000. Outcome at age 4 years in offspring of women with maternal phenylketonuria: the Maternal PKU Collaborative Study. JAMA 283:756-62 (Pubitemid 30084615)
70. Weaver MA, Johnson A, Singh RH, WilcoxWR, Lloyd-Puryear MA, Watson MS. 2010. Medical foods: inborn errors of metabolism and the reimbursement dilemma. Genet. Med. 12:364-69